Sophia Genetics

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$17,733
$15,853
$15,808
$15,779
Gross Profit
12,102
10,654
10,776
10,405
EBITDA
-7,946
-13,150
-12,995
-17,424
EBIT
-10,233
-15,363
-15,032
-19,483
Net Income
-15,158
-18,438
-15,193
-13,704
Net Change In Cash
17,733
15,853
15,808
15,779
Free Cash Flow
-12,541
-9,363
-11,501
-15,797
Cash
80,226
95,787
105,396
103,735
Basic Shares
66,062
66,383
65,916
65,308

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$65,173
$62,371
$47,560
$40,450
Gross Profit
43,937
42,913
31,254
25,221
EBITDA
-50,761
-70,700
-82,667
-70,837
EBIT
-59,357
-79,036
-88,238
-74,446
Net Income
-62,493
-78,981
-87,449
-73,675
Net Change In Cash
65,173
62,371
47,560
40,450
Free Cash Flow
-50,998
-57,801
-80,474
-64,610
Cash
80,226
123,251
161,305
192,962
Basic Shares
66,062
64,750
64,099
63,857

Earnings Calls

Quarter EPS
2024-12-31
-$0.11
2024-09-30
-$0.27
2024-06-30
-$0.23
2024-03-31
-$0.21